Analysis of radiation-induced liver disease using the Lyman NTCP model

Lawrence, 1995, Hepatic toxicity resulting from cancer treatment, Int J Radiat Oncol Biol Phys, 31, 1237, 10.1016/0360-3016(94)00418-K Ingold, 1965, Radiation hepatitis, AJR Am J Roentgenol, 93, 200 Poussin-Rosillo, 1976, Hepatic radiation tolerance in Hodgkin’s disease patients, Radiology, 121, 461, 10.1148/121.2.461 Russell, 1993, Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases, Int J Radiat Oncol Biol Phys, 27, 117, 10.1016/0360-3016(93)90428-X Austin-Seymour, 1986, Dose volume histogram analysis of liver radiation tolerance, Int J Radiat Oncol Biol Phys, 12, 31, 10.1016/0360-3016(86)90412-8 Dawson, 2000, Escalated focal liver radiation and concurrent hepatic artery fluorodeoxyuridine for unresectable intrahepatic malignancies, J Clin Oncol, 18, 2210, 10.1200/JCO.2000.18.11.2210 Robertson, 1997, Long-term results of hepatic artery fluorodeoxyuridine, and conformal radiation therapy for primary hepatobiliary cancers, Int J Radiat Oncol Biol Phys, 37, 325, 10.1016/S0360-3016(96)00528-7 Mohiuddin, 1996, Combined liver radiation and chemotherapy for palliation of hepatic metastases from colorectal cancer, J Clin Oncol, 14, 722, 10.1200/JCO.1996.14.3.722 Lyman, 1985, Complication probability as assessed from dose-volume histograms, Radiat Res Suppl, 8, S13, 10.2307/3583506 Jackson, 1993, Probability of radiation induced complications for normal tissues with parallel architecture subject to non-uniform irradiation, Med Phys, 20, 613, 10.1118/1.597056 Niemierko, 1993, Modeling of normal tissue response to radiation, Int J Radiat Oncol Biol Phys, 25, 135, 10.1016/0360-3016(93)90156-P Yorke, 1999, Can current models explain the lack of liver complications in Y-90 microsphere therapy?, Clin Cancer Res, 5, 3024s McGinn, 1998, Treatment of intrahepatic cancers with radiation doses based on a normal tissue complication probability model, J Clin Oncol, 16, 2246, 10.1200/JCO.1998.16.6.2246 Kutcher, 1989, Calculation of complication probability factors for non-uniform normal tissue irradiation, Int J Radiat Oncol Biol Phys, 16, 1623, 10.1016/0360-3016(89)90972-3 Ten Haken, 1993, Use of Veff and iso-NTCP in the implementation of dose escalation protocols, Int J Radiat Oncol Biol Phys, 27, 689, 10.1016/0360-3016(93)90398-F Lawrence, 1992, The use of 3-D dose volume analysis to predict radiation hepatitis, Int J Radiat Oncol Biol Phys, 23, 781, 10.1016/0360-3016(92)90651-W Jackson, 1995, Analysis of clinical complication data for radiation hepatitis using a parallel architecture model, Int J Radiat Oncol Biol Phys, 31, 883, 10.1016/0360-3016(94)00471-4 Ten Haken, 1991, Technical considerations in the use of 3-D beam arrangements in the abdomen, Radiother Oncol, 22, 19, 10.1016/0167-8140(91)90065-O Balter, 1998, Improvement of CT-based treatment-planning models of abdominal targets using static exhale imaging, Int J Radiat Oncol Biol Phys, 41, 939, 10.1016/S0360-3016(98)00130-8 Fraass, 1987, 3-D treatment planning, 273 Roberts, 1993, The delay before onset of accelerated tumour cell repopulation during radiotherapy, Radiother Oncol, 29, 69, 10.1016/0167-8140(93)90175-8 Cox, 1989, 179 Agresti, 1990 Burman, 1991, Fitting of normal tissue tolerance data to an analytic function, Int J Radiat Oncol Biol Phys, 21, 123, 10.1016/0360-3016(91)90172-Z Langer, 1998, A test of the claim that plan rankings are determined by relative complication and tumor-control probabilities, Int J Radiat Oncol Biol Phys, 41, 451, 10.1016/S0360-3016(98)00057-1 Russell, 1993, Accelerated hyperfractionated hepatic irradiation in the management of patients with liver metastases, Int J Radiat Oncol Biol Phys, 27, 117, 10.1016/0360-3016(93)90428-X Emami, 1991, Tolerance of normal tissue to therapeutic irradiation, Int J Radiat Oncol Biol Phys, 21, 109, 10.1016/0360-3016(91)90171-Y Eisbruch, 1999, Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer, Int J Radiat Oncol Biol Phys, 45, 577, 10.1016/S0360-3016(99)00247-3 Kwa, 1998, Radiation pneumonitis as a function of mean lung dose, Int J Radiat Oncol Biol Phys, 42, 1, 10.1016/S0360-3016(98)00196-5 Lujan, 1999, Quantization of setup uncertainties in 3-D dose calculations, Med Phys, 26, 2397, 10.1118/1.598756 Dawson, 2001, The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy, Int J Radiat Oncol Biol Phys, 51, 1410, 10.1016/S0360-3016(01)02653-0 Wong, 1999, The use of active breathing control (ABC) to reduce margin for breathing motion, Int J Radiat Oncol Biol Phys, 44, 911, 10.1016/S0360-3016(99)00056-5 Ten Haken, 1997, Potential benefits of eliminating planning target volume expansions for patient breathing in the treatment of liver tumors, Int J Radiat Oncol Biol Phys, 38, 613, 10.1016/S0360-3016(97)00009-6 Symon, 2001, Selective radioprotection of hepatocytes by systemic and portal vein infusions of amifostine in a rat liver tumor model, Int J Radiat Oncol Biol Phys, 50, 473, 10.1016/S0360-3016(01)01522-X Billingsley, 1986